39results about How to "No reactivity found" patented technology

A traditional Chinese medicinal health-care wine is made from the following raw materials of: by weight, corn flour, Radix Astragali, Chinese angelica, Radix Rehmanniae Preparata, polygonatum rhizome, Schisandra chinensis, Chinese yam, Chinese wolfberry and Radix Codonopsis. A preparation method of the wine provided by the invention comprises the following steps of: airing the above traditional Chinese medicinal raw materials, crushing to a powder, adding the above corn flour, adding water which accounts for 30-35% of the total weight of the raw materials as well as 4-6% of distiller's yeast with stirring, fermenting at the temperature of 25-32 DEG C for 8-10 days, followed by distillation to obtain the traditional Chinese medicinal health-care wine of 32%(v / v). The traditional Chinese medicinal health-care wine provided by the invention is prepared by the adoption of pure Chinese herbal medicines, contains no hormone and has no toxic and side effect. The health-care wine should be drunk 1-2 times per day with a drinking volume of 25ml for each time, and has a great curative effect for treating diseases such as diabetes and cardio cerebrovascular diseases with the effective rate being over 98%. The product provided by the invention mainly has functions of enhancing body immunity, invigorating vital energy and nourishing blood, and has effects of resisting aging, resisting fatigue, prolonging life span and preventing a plurality of diseases if drunk for a long time.

The invention is concerned with a kind of new Chinese traditional medicine combination stuff and its preparation method for mildly reinforcing the kidney-yang, relating to epimedium, Curculigo orchioides, broomrape, medlar, dogwood fruit, morinda root, ginseng, cassia and eagle ood. Grind ginseng into powder for using, break cassia and eagle ood and get clear paste and thick paste by distill with ethanol and water. Mix the powder of ginseng with the said clear paste and thick paste, dry and grind into powder in decompression and get the purpose preparation of this Chinese traditional medicine combination stuff. This combination stuff has reliable effect to cure the illness of insufficiency of kidney-yang, and it is a steady and credible method.

The invention discloses a Chinese medicinal composition having functions of resolving phlegm, relieving cough, promoting blood flow, dispelling stasis and preparing method, wherein the Chinese medicinal composition is prepared from astragalus root, earthworm, leeches, root of red rooted saliva, kudzu vine root, musk, boneol and buffalo horn concentrated powder through steps of disintegrating, water extracting, concentrating, drying and disintegrating into fines, mixing the fines with concentrated buffalo horn powder and borneol homogenously.

The invention provides a traditional Chinese medicinal composition for enlivening spleen, reducing fever and promoting the secretion of the body fluid. The invention also discloses the process for preparing the pharmaceutical composition, which is a safe and effective antihypelipidemic medicament suitable for non-insula dependent diabetes patients.

A Chinese medicine for treating mastoplasia and breast edema is prepared from 10 Chinese-medicinal materials including turtle shell, curcuma root, bupleurum root, prunella spike, etc.

The invention provides an identification method of a traditional Chinese medicine heart calming and mind tranquilizing preparation, and belongs to the field of drug quality control. The identification method comprises thin-layer identifications of grass-leaved sweetflag rhizome, polygala root and red sage root, has the characteristics of strong specificity, rapidness and convenient operation, overcomes the shortage of incomprehensiveness of conventional detection methods of heart calming and mind tranquilizing capsules, and thus the product quality of the drugs can be effectively controlled. Through clinical observation of 440 patients in clinic, it has been shown by the cure results that the symptoms, which are caused by climacteric syndrome and neurasthenia, such as vexation and sleeplessness, dreaminess, restless sleep, dizziness and tinnitus, dry mouth and pharynx, dysphoria in chestpalms-soles, palpitation and sweating, and amnesia, are prominently improved after the patients of the curing group have been cured with the drugs. The heart calming and mind tranquilizing capsule can prominently improve the clinical symptoms caused by climacteric syndrome and neurasthenia, and has a good clinical curative effect. The cure rate, effective-showing rate and effective rate of the curing group are 56.67%, 18.75% and 15.42%, and the total effective rate is 90.83%. No prominent adverse drug reaction or toxic and side effect has been found after taking the drug, so the drug is safe and reliable in clinic usage.

The invention discloses a Chinese medicine compound preparation for treating vulvovaginitis and venereal diseases and a method for preparing the same. The compound preparation is prepared from active ingredients including isatis root, patrinia, glabrous greenbrier rhizome, bugleweed, dyer woad leaves, radix sophorae flavescentis, cicada ecdysis, cnidium fruit, fructus kochiae, radix stemonae, borneol and the like. The method comprises the following steps: besides the borneol, decocting the active ingredients with water for two times, 1.5 hours for each time; filtering the mixture, and combining the filtrate; adding the borneol which is ground into fine powder into the mixture; and then adding 0.2 percent tween 80 for keeping stand, canning the mixture, and performing circulation steam sterilization at a temperature of 100 DEG C for 30 minutes to obtain the finished product. Through applying a mixed lotion of various antibacterial drugs, antiviral drugs and antipruritic drugs, the Chinese medicine compound preparation not only achieves the aim of treating the vulvovaginitis, but also has better effect on treating the venereal diseases such as verruca acuminata, gonococcal vaginitis and the like, and opens up a new way of conservative treatment of the venereal diseases.

The invention relates to a medicine composition for treating wound infection after vein blood sampling and a preparing method thereof. The traditional Chinese medicine composition is prepared from, by weight, 10-30 parts of dried ginger, 10-35 parts of hawthorn fruit, 10-35 parts of herba eupatorii, 10-40 parts of uncaria rhynchophylla, 10-40 parts of mint, 10-30 parts of clove, 10-35 parts of ginseng, 15-55 parts of gypsum, 5-25 parts of white gourd peels, 5-25 parts of linseed, 5-25 parts of fructus hippophae, 10-30 parts of medicine terminalia fruit, 10-30 parts of radix ligustici sinensis, 10-35 parts of radix isatidis and 10-40 parts of licorice roots through the processes of alcohol leaching and water decocting, 270 cases of wound infection after vein blood sampling are treated, the total effective rate reaches 94.4%, the effect is remarkable, adverse reaction and the toxic and side effects are not found, and it shows that the medicine composition is remarkable in effect of treating wound infection after vein blood sampling and has good popularization value.

The invention provides a drug for treating blood-deficiency and wind-dry type psoriasis, which is characterized by being prepared from the following traditional Chinese medicine raw materials: black snake, scorpion, centipede, periostracum cicadae, dried rehmannia root, prepared rehmannia root, asparagus, lilyturf root, angelica, radices salviae miltiorrhizae, lignum millettiae, radices curcumae zedoariae, bombyx batryticatus, Polygonum multiflorum Thunb, cortex dictam, nidus vespae and liquorice. The drug has the effect on tonifying the blood and nourishing Yin, activating blood and dissolving stasis and expelling the wind to resolve amass together. The drug is symptomatic and is used for treating blood-deficiency and wind-dry type psoriasis and carries out treatment from pathogeny: yingblood deficiency, unsmooth and QI and blood and windchill attack, thereby effectively treating blood-deficiency and wind-dry type psoriasis.

The invention discloses a medicine for treating rheumatoid arthritis and a preparation method thereof. The medicine is prepared form 5 to 60 parts by weight of Radix Astragali, 5 to 15 parts by weight of orienavine and 1 to 15 parts by weight of scorpion. The medicine composition provided by the invention can be utilized for treating rheumatoid arthritis and has the advantages of low cost, safetyfor taking, no toxic and side effect, and feasibility of long term use. The invention also discloses a preparation method of capsules containing the medicine. The capsules prepared by the preparationmethod has the advantages of no stinking smell of Chinese medicine materials, good taste, convenience for taking, fast disintegration speed which is faster than the disintegration speeds of a tablet and a pill, and fast release of medicines which are in the capsules, is not effected by an adhesive and a pressure and can diffuse fast in gastric juice to play effects fast.

The invention relates to a drug composition for treating depression and a preparation thereof. The drug composition is prepared from, by weight, rirr, garnet, incarvillea, anisetree bark, radix isatidis, guanmutong, concanavalin, meconopsis, sub rhubarb, pulsatilla, cinnamon, galangal, licorice through the process of alcohol extraction, water extraction and the like. 360 depression patients have been treated. The total effective rate is as high as 94.1%. The treatment effect is obvious. No negative reaction, side effect or toxic effect are reported indicating the drug composition has an obvious treatment effect to depression patients, and possesses good promotion value.

The invention relates to a medicine composition for treating injuinal hernia and a preparation method thereof. The medicine composition is prepared from the following medicines in parts by weight: tatarian aster root, gecko, fructus ligustri lucidi, radix berberidis, folium callicarpae macrophyllae, folium ginseng, caulis clematidis armandii, radix semiaquilegiae, fructus teminaliae billaricae andhirudo which are subjected to processes of alcohol extraction, water extraction and the like. 120 injuinal hernia patients are treated, the total effective rate reaches 94% on average, which is obviously higher than that of a control group, the effect is obvious, and untoward effects and toxic and side effects are not found, so that the medicine composition has significant efficacy in the aspectof treating the injuinal hernia patients and has a good popularization value.

The invention relates to a medicine composition for treating blood stasis around wounds formed after blood sampling and a method for preparing the same. The medicine composition is prepared by using the following medicines: eucommia bark, smoked plum pulp, radix salviae miltiorrhizae, cablin patchouli herb, black catechu, radix paeoniae alba, cassia bark, cape jasmine, baical skullcap root, common coltsfoot flower and garden burnet root. The medicine composition is prepared through processes such as alcohol leaching and water decoction. Totally 450 cases of blood stasis around wounds formed after vein blood sampling are treated, the total effective rate reaches 98.9 percent, the effect is remarkable, no adverse effect and toxic and side effects are found, and it indicates that the medicine composition has a remarkable effect of treating blood stasis around wounds formed after vein blood sampling and has great popularization value.

The invention discloses a medicine composition for treating gout and a preparation method of the medicine composition. The medicine composition is prepared from the following medicines in parts by weight according to the following steps: rhizoma cynanchi stauntonii, rhizoma menispermi, exocarpium citrus grandis, concha haliotidis, pericarpium trichosanthis, rice sprouts, radix tinosporae, folium rhododendri daurici, herba picriae, radix astragali seu hedysari, centipede and Chinese angelica, and is prepared by alcohol extraction and water boiling processes; a test group treats 405 gout patients, and main clinical manifestations of the patients include arthralgia, pressing pain, acute inflammation, activity limitation and overproof uric acid value; the average effective rate of each embodiment is 96.8 percent, and the effect is obvious; furthermore, no adverse reaction and no toxic and side effects are found, so that the medicine composition disclosed by the invention is outstanding in gout treatment effect, and has a good popularization value.

The invention is concerned with the capsule for treat coronary heart disease, the compounding is: gen-seng, notoginseng, amber, cunpu, nard. It is: processes to parch, grinds and sifts by 120 meshes - 150 meshes, puts into capsule. The invention is safety, easy to taking, and simple technics.

The invention discloses a traditional Chinese medicine for treating chronic colitis and a preparation method thereof. The traditional Chinese medicine is prepared from the following raw materials in parts by weight: 15 to 22 parts of tuber of dwarf lilyturf, 10 to 14 parts of morinda officinalis, 5 to 9 parts of rehmanniae radix, 6 to 12 parts of folium isatidis, 16 to 22 parts of licorice, 9 to 14 parts of alpinia oxyphylla, 4 to 9 parts of peach seed, 12 to 18 parts of dark plum, 6 to 11 parts of rabdosia rubescens, 3 to 6 parts of balloonflower root, 14 to 19 parts of broom cypress fruit, and 4 to 8 parts of leaf of eucalyptus robusta. The preparation method comprises the following steps: washing raw materials, cutting and drying raw materials, adding water into tuber of dwarf lilyturf, morinda officinalis, and the like, decocting tuber of dwarf lilyturf, morinda officinalis, and the like for three times, condensing the decoction, carrying out alcohol precipitation, drying the precipitate to obtain extract (A); adding ethanol into rabdosia rubescens, balloonflower root, and the like, performing reflux, drying to obtain extract (B); merging extract (A) and extract (B), grinding, and mixing. The provided traditional Chinese medicine can quickly relieve the clinical symptoms of ulcerative colitis patients such as diarrhea, pus and blood stool, stomachache, and the like; can prominently improve the pathological change of intestinal mucosa, eliminate the inflammation medium, and promote the healing of ulcer; and achieves a good curative effect. The total effective rate is 96%, and no adverse reaction, side effect, or toxic effect has been found.

The invention provides an ear washing liquid and a preparation method thereof. The ear washing liquid mainly comprises the raw materials of fresh abutilon indicum, fresh artemisia apiacea, fresh andrographis paniculata, fresh grapefruit leaf, fresh mint, fresh saxifraga stolonifera, fresh kudzu, fresh lophatherum gracile, fresh cordate houttuynia, fresh honeysuckle rattan, and fresh dandelion, and is prepared according to the processes of primary distilling, decocting, redistilling and the like. The ear washing liquid has a better absorption effect, has the obvious effects of sterilizing and diminishing inflammation, is strong in adaption, plays a role in sterilizing and diminishing inflammation of most ear inflammation, is reasonable in formula, simple in manufacturing process, high in safety, and free of toxic or side effect and other untoward effects, and has a quite excellent development and application prospect, and is suitable for large-scale popularization and application.

The invention relates to a pharmaceutical composition for treating infantile dyspepsia and a preparation method thereof. The pharmaceutical composition is made from, by weight, Herba Lysionoti Pauciflori, Trametes versicolor, Cortex Moutan, Spora Lygodii, Rhizoma Drynariae, Endothelium Corneum Gigeriae Galli, Fructus Ligustri Lucidi, Herba Lobeliae Chinensis, Herba Leonuri, Rhizoma Panacis Japonici, and Fructus Crataegi via the steps of decocting and the like; 567 cases with infantile dyspepsia treated show that average effective rate of the embodiments is up to 97.7%, the effect is significant, there is no adverse reaction and toxic or side effect discovered, and it is indicated that the pharmaceutical composition has significant therapeutic effect in terms of treating infantile dyspepsia and has good popularization value.

The invention relates to a medicine composition for assisting coronary heart disease postoperative recovery and a preparation method thereof. The medicine composition is prepared from the following medicine in parts by weight: marrubium incisum, diaphragma juglandis, stachyurus pith, puffball, linseeds, crinis carbonisatus, herba polygoni avicularis, Chinese violet, radix serratulae chinensis, trichosanthes palmate, menthol and flos magnolia through the processes of water boiling and alcohol soaking. After the treatment on 360 cases of coronary heart disease postsurgical patients, the total effectiveness rate reaches 94.4 percent; the effect is obvious; the adverse effects and toxic and side effects are not discovered; the result shows that the medicine composition has the obvious curative effect on coronary heart disease postsurgical recovery, and has good popularization values.

The invention discloses an analgesic granule and its preparing method, wherein the granule is prepared from 10-20 parts of bupleurum root, 7-14 parts of Schizonepeta tenuifolia, 7-14 parts of silver flower, 10-20 parts of baikal skullcap root, and 7-14 parts of prepared soybean.

The invention provides a kudzuvine root blood sugar reducing capsule and a preparation method. The kudzuvine root blood sugar reducing capsule is prepared from the following raw materials in parts by weight: 9-30 parts of radix astragali, 10-30 parts of rehmannia root, 15-30 parts of mulberries, 15-30 parts of figwort root, 15-30 parts of kudzuvine root, 12-25 parts of dark plum fruit and 10-30 parts of mulberry leaves. The preparation method comprises the steps of grinding the mulberries into fine powder and sieving the fine powder, adding moderate 65-75% ethanol to kudzuvine root, and carrying out extraction to obtain a reflux extraction solution; adding water to radix astragali, rehmannia root, figwort root, dark plum fruit and mulberry leaves or adding water to immerse the drugs, and decocting the drugs to obtain decoction; concentrating the decoction to obtain clear paste, adding ethanol to enable the ethanol content to be 55-65%, and stirring the mixture uniformly to obtain an ethanol blended solution; combining the reflux extraction solution with the ethanol blended solution, recovering the ethanol, concentrating the solution to obtain thick paste, adding the mulberry powder, mixing the thick paste with the mulberry powder, drying and grinding the mixture, sieving the powder with a 100-mesh sieve, and then filling the powder into a capsule shell, thus preparing the capsule. The capsule has the advantages that the capsule can not lead to hypoglycaemia complications after being taken for a long time, does not have any toxic or side effect or adverse reaction, is better than existing medicaments for treating hyperglycemia, such as insulin, Apianbaoxin and the like, simultaneously has an immunoregulation health care function, and is different from general blood sugar reducing drugs.

The invention relates to the field of medicines, and in particular relates to a prescription of a medicine for treating calculi. The medicine is prepared from the following raw materials in parts by weight: 30-60 parts of spora lygodii, 15-28 parts of folium pyrrosiae, 4-8 parts of radix fici microcarpue aeria, 2-7 parts of fructus amomi, and 3-9 parts of white atractylodes rhizome. According to the prescription of the medicine for treating calculi, the monarch drugs and the ministerial drugs are mixed, so that the medicine has the efficacies of tonifying the kidney and the spleen and inducing diuresis, dilating the ureter, and promoting blood circulation to remove meridian obstruction, and can dissolve the calculi layer by layer after acting to the calculi, so that kidney calculi are reduced and finally discharged out of the body; with the adoption of the manner of dissolving the calculi layer by layer, one part of fine powder calculi can be discharged first, then the rest calculi can be discharged out of the body at once, so that the calculi removal is complete and clean, and the calculi removal time is greatly shortened.

The invention relates to a pharmaceutical composition for treating gastric ulcer and a preparation method thereof. The pharmaceutical composition is prepared from, by weight part, fructus aeclis marmeli, micalex, juniperus chinensis twigs, flos pyrethrum tatsienense, rhizoma tinospora sinensia, coral, radix aconiti, lacca, periostracum cicadae, semen lactucae, semen brassicae campestris and licorice roots, all the raw materials are prepared into the pharmaceutical composition by using a hydroalcoholic technology, 450 patients suffering from the gastric ulcer are treated, the average effectiverate reaches 94.89%, the effect is obvious, no adverse reactions and no side and toxic effects are found, it is shown that the pharmaceutical composition has a significant curative effect on treatmentof the gastric ulcer, and the pharmaceutical composition has a high popularization value.

The invention relates to a medicine composition for treating bone fracture and a preparation method thereof. The medicine composition is prepared from the following medicinal materials in parts by weight: butterflybush flowers, coix seeds, pink herb, coral, glossy privet fruit, cynanchum atratum, polygala tenuifolia, schizonepeta spike, cape jasmine, travertine, safflower carthamus and licorice roots by alcohol extraction, decoction and other processes. Observation on clinical curative effects of 1068 bone fracture cases indicate that the medicine composition has a remarkable curative effect on bone fracture, ostealgia, blood stasis, dislocation, joint sprain, and pulled muscle caused by traumatic injuries, has a total effective rate of 96 percent, and does not have adverse response, toxic or side effect. Therefore, the medicine composition has a remarkable curative effect on bone injury treatment, and has an excellent popularization value.

The invention relates to a drug combination for bleeding after vein blood sampling and a preparation method of the drug combination. The drug combination is prepared from the following medicines in parts by weight, magnetite, common hogfenneI roots, radix achyranthis bidentatae, selfheal spike, radix gentianae macrophyllae, semen momordicae, lophatherum gracile, allium macrostemon, tangerine peel, schisandra chinensis and fructus perillae. The medicines are boiled and alcoholically extracted to form the drug combination, the drug combination is used for 360 bleeding patients after vein blood sampling, total effective rate of bleeding stop averagely reaches 98.9%, bleeding stop effects are obvious, and adverse reaction, toxic and side effect cannot be discovered, so that the drug combination has remarkable treatment effects for bleeding after vein blood sampling and good popularization values.

The invention relates to a pharmaceutical composition for treating pediatric hernia and a preparation method thereof. The pharmaceutical composition is prepared from the following medicines in parts by weight: sesamum indicum, cinnamon seeds, jequirity seeds, fistular onion seeds, semen irisis, pyrethri tatsienensis, fructus amomi rotundus, lac, fructus malvae vertillatae, coriander, rhizoma drynariae and Japanese coral through processes such as alcohol extraction and water extraction. 360 pediatric hernia patients are treated, the total effective rate averagely reaches 95%, the effect is obvious, no adverse reaction and toxic and side effect is found, and thus it is indicated that the pharmaceutical composition is significant in effect for treating the pediatric hernia patients, and has good popularization value.

Disclosed are Chinese herbal medicine for treating endocrine dyscrasia and its preparation method.The Chinese herbal medicine comprises, by weight, 50-80 parts of astragalus membranaceus, 30-50 parts of radix aucklandiae, 25-40 parts of radix bupleuri, 15-30 parts of semen coicis, 15-30 parts of polygala tenuifolia, 15-30 parts of radix dipsaci, 30-50 parts of dandelion, 20-40 parts of leonurus, 20-50 parts of red-rooted salvia, 10-20 parts of oyster, 20-40 parts of rhizome of rehmannia, and 15-25 parts of seaweed.The Chinese herbal medicine is prepared by alcohol extraction, boiling and mixing.Through clinical practice, total efficiency is up to 94%, and the Chinese herbal medicine has excellent effect and no adverse effect, toxic and side effect.The Chinese herbal medicine for treating endocrine dyscrasia has excellent curative effect and high popularization value.

The invention relates to a pharmaceutical composition for treating dermatitis due to ionizing radiation and a preparation method thereof. The pharmaceutical composition is prepared by the following medicines in parts by weight: mustard seeds, Radde anemone rhizome, perilla stems, gecko, Ajuga ciliate, orostachys, henbane seeds, typhonium rhizomes, willowleaf swallowwort rhizomes, Kochia scoparia, and licorice; the pharmaceutical composition is prepared by processes of decoction with water, stir frying with fire, and alcohol leaching. The pharmaceutical composition was used for treating 270 patients with dermatitis due to ionizing radiation, the total effective rate reaches 94.4%, effects are obvious, and adverse reactions as well as toxic and side effects are not discovered; the pharmaceutical composition has substantial curative effects for treating dermatitis due to ionizing radiation, and has good promotion values.

The invention relates to pharmaceutical composition for treating flaccidity syndrome and a preparation method of the pharmaceutical composition. The pharmaceutical composition is prepared from following medicines in parts by weight with a water extracting process: tabasheer, fructus gleditsiae abnormalis, herba pogostemonis, herba epimedii, eggplant root, cortex illicii, fructus aurantii, poria cocos, rhizoma atractylodis, angelica sinensis, semen plantaginis, radix curcumae and radix glycyrrhizae. The pharmaceutical composition is applied to treatment of 450 cases of patients with flacciditysyndrome, the total effective rate reaches 96%, the effect is obvious, no side reactions or toxic and side effects are produced, and it is indicated that the pharmaceutical composition has a remarkable curative effect on the patient with the flaccidity syndrome and has good popularization value.